Who is eligible for clinical trial NCT01976247?

Participants must meet protocol criteria for Abdominal Fat. Confirm exact inclusion and exclusion requirements with the study coordinator.

Does clinical trial NCT01976247 provide travel or cost reimbursement?

Check with the site coordinator at the participating facility for travel and lodging stipend availability, and for which routine-care costs are covered.

🏛️ Verified NIH Record • Updated 2026-06-29

A Pilot Study Testing a Noninvasive Cryolipolysis Device Versus a High Intensity Focused Ultrasound Device for Fat Reduction (NCT01976247)

🔵 Active, Not Recruiting Phase1 ⚙️ Medical Device Protocol Sponsor: Northwestern University

🩺 Plain-English Summary (8th-Grade Level)

The purpose of this study is to compare the safety and effectiveness of the Zeltiq System and LipoSonix System for fat reduction and improving body shape.

Who can join: To join this study, participants generally need to meet the listed inclusion criteria (6 items) and avoid the listed exclusions (10 items).

Location: Northwestern University Department of Dermatology — Chicago, Illinois

📋 "Do I Qualify?" — 1-Minute Self Screener

Instant Checklist

Check every box below. If you can check all of them, you may meet the study's basic screening requirements (final eligibility is confirmed by the site team).

Female subjects ages 30-65 years old.
Body mass index (BMI) between 18 and 29.99. (BMI is defined as weight in pounds multiplied by 703 divided by the square of the height in inches).
Subjects are in good health.
Willing and able to abstain from partaking in any treatment other than the study procedure (existing or new) to promote body contouring and/or weight loss during the course of study participation.
Subjects agree to maintain their weight (i.e. within 5 pounds) by not making any changes to diet or lifestyle during the study.
The subjects have the willingness and the ability to understand and provide informed consent for the use of their tissue and communicate with the investigator.

Usually NOT eligible if any of the following apply:

Exclusion Criteria:
Pregnant or lactating or intends to become pregnant in the next 9 months.
Unable to understand the protocol or to give informed consent.
Any previous and/or pending procedures at the treatment area or that may likely affect the treatment area.
Pending and/or anticipated major change in diet or exercise pattern in the six weeks following the last treatment or who has taken diet pills within the last 6 months..
History of asthma or chronic obstructive pulmonary diseases.
Active skin disease or skin infection in the treatment area.
Bleeding tendency or coagulopathy.
Subjects who are allergic to lidocaine.
Any other condition that would, in the professional opinion of the investigator, potentially affect response or participation in the clinical study, or would pose as an unacceptable risk to the subject.

🔍 Extracted verbatim from the official NIH eligibility criteria. Always confirm with the study coordinator.

📍 All Participating Trial Locations (1 Sites)

Northwestern University Department of Dermatology — Chicago, Illinois

💰 Cost, Insurance & Patient Rights

100% Free Items: The investigational treatment and protocol-required procedures are supplied at zero cost by the sponsor.
Routine Patient Care: Under federal law (ACA § 2709) and many state statutes, routine care costs are covered during participation.
Voluntary Participation: You may withdraw at any time without affecting your standard medical care.

🏛️ View Official NIH Record ↗